bioRxivBioengineering
Light induced expression of gRNA allows for optogenetic gene editing of T lymphocytes in vivo
D. A. Velasquez Pulgarin, N. Pelo, L. Ferrandiz, T. Trselic, W. A. Nyberg, G. L. Bowlin, A. Espinosa
Abstract
There is currently a lack of tools capable of perturbing genes in both a precise and spatiotemporal fashion. CRISPRs ease of use and flexibility, coupled with lights unparalleled spatiotemporal resolution deliverable from a controllable source, makes optogenetic CRISPR a well-suited solution for precise spatiotemporal gene perturbations. Here we present a new optogenetic CRISPR tool, BLU-VIPR, that diverges from prevailing split-Cas design strategies and instead focuses on optogenetic regulation of gRNA production. This simplifies spatiotemporal gene perturbation and works in vivo with cells previously intractable to optogenetic gene editing. We engineered BLU-VIPR around a new potent blue-light activated transcription factor and ribozyme-flanked gRNA. The BLU-VIPR design is genetically encoded and ensures precise excision of multiple gRNAs from a single mRNA transcript, allowing for optogenetic gene editing in T lymphocytes in vivo.
- organism: mouse
- assay: CRISPR screen
- research focus: gene regulatory network inference
- research focus: perturbation response prediction
- approach: optimal transport
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Optical control of CRISPR-Cas editing with cyclically caged guide RNAs
- Spatial and temporal control of CRISPR/Cas9-mediated gene editing delivered via a light-triggered liposome system
Y. A. Aksoy, W. Chen, … W. Deng·bioRxiv·Aug 5, 2019
- Virus-like particle delivery enables orthogonal genome editing in vitro and in vivo
Soochul Shin, Bae-Geun Nam, … Sangsu BAE·bioRxiv·Feb 11, 2026
- Real-Time Observation Of Light-Controlled Transcription In Living Cells
A. Rademacher, F. Erdel, … K. Rippe·bioRxiv·Apr 28, 2017
- Naive and in vitro-activated primary mouse CD8+ T cells retain in vivo immune responsiveness after electroporation-based CRISPR/Cas9 genetic engineering
P. Pfenninger, L. Yerly, J. Abe·bioRxiv·Sep 14, 2021
- Local optogenetic control of genome editing and tumorigenesis in vivo using wireless implantable optoelectronics
Trisha Bansal, Min‐Kyu Lee, … Andrei V. Karginov·bioRxiv·Jun 12, 2025